The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.

Article Details

Citation

Copy to clipboard

Thayer SA, Fairhurst AS

The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.

Mol Pharmacol. 1983 Jul;24(1):6-9.

PubMed ID

6865927 [ View in PubMed

]

Abstract

The calmodulin inhibitors R24571 and trifluoperazine were found to inhibit competitively the binding of [3H]nitrendipine to a 48,000 X g particulate fraction of rat brain with IC50 values of 1.0 and 18.8 microM, respectively. Equilibrium dialysis was used to test the ability of the dihydropyridines nitrendipine, felodipine, and nicardipine to inhibit the binding of [3H]chlorpromazine, [14C]pimozide, and 45Ca2+ to calmodulin. At dihydropyridine concentrations near the limit of solubility (10 microM), the only significant effect in these three binding experiments was a 26% inhibition of [14C]pimozide binding to calmodulin by nicardipine, indicating that the dihydropyridines do not bind to the same site on calmodulin as chlorpromazine, pimozide, or calcium. Equilibrium dialysis was also used to determine the ability of the dihydropyridines to interact directly with calmodulin. [3H] Nitrendipine bound to calmodulin in a calcium-dependent manner; however, this binding was of a low-affinity, unsaturable nature. These results suggest that the dihydropyridine drugs do not interact with calmodulin at concentrations that are pharmacologically significant.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Nicardipine	Calmodulin	Protein	Humans	Unknown	Other/unknown	Details